Key points are not available for this paper at this time.
This cohort study uses emulation target trial methods to evaluate whether semaglutide is associated with lower rates of opioid overdose among patients with type 2 diabetes (T2D) and opioid use disorder (OUD).
Wang et al. (Wed,) studied this question.